Your tale reveals a different moral than you otherwise intended. It's not so much that VIVO should be higher. It's that the other Canandian LP's should be sub $1. I only like Aleafia's and Aphria's Q 3 & 4 guidance or what they inferred. The others have promised more of the same. Here’s even more of a shock when comparing the numbers... Quarter 2 of 2020... ogi 18m revenue with a 90m lost and a 350m evaluation... acb 75m revenue with 150m lost and a 1.5b evaluation... weed 110m revenue with 110m lost and a 8.2b evaluation.... but vivo with 10m revenue and 4.6 m lost is valued at 67m...... Things that make you go Hmmmmmmmmmmm... 'Ditryin'